DUBLIN--(BUSINESS WIRE)--The "Point of Care Diagnostics Market by Product, End-User and Mode of Prescription - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022" report has been added to Research and Markets' offering.
The global point of care diagnostics market size is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022.
Point of Care Diagnostics Market by Kits Product (Glucose Monitoring, Infectious Disease Testing, Pregnancy And Fertility Testing, Hematology Testing, Cardiometabolic Monitoring, Urinalysis Testing, Coagulation Monitoring, Tumor Markers Testing, Cholesterol Test Strips, Drugs Of Abuse Testing, Fecal Occult Testing) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022
The point of care tests refers to the diagnostic procedures which are conducted outside of the laboratories. Point of care diagnostic procedures are carried out by various point of care diagnostics devices which are used to test cholesterol and glucose levels, enzyme analysis, drugs of abuse testing, diagnosis of infectious diseases and pregnancy testing. In addition, cardiac markers, fecal occult blood tests and blood gases tests can also be performed by using point of care diagnostic devices.
Rising prevalence of various chronic and infectious diseases such as cardiac diseases, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) play a pivotal role in the growth of the global point of care diagnostics market.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 World Point of Care Diagnostics Market, By Product
Chapter 5 World Point of Care Diagnostics Market, By End User
Chapter 6 World Point of Care Diagnostics Market, By Mode of Prescription
Chapter 7 World Point of Care Diagnostics Market, By Geography, 2015-2022
- Abbott Laboratories
- Siemens AG F
- Hoffmann-La Roche Ltd
- Sinocare Inc
- Johnson & Johnson
- Sysmex Corporation
- Nova Biomedical
- Danaher Corporation
- Becton Dickinson and Company
- BioMrieux SA
- Bio-Rad Laboratories
For more information about this report visit https://www.researchandmarkets.com/research/dg63g5/point_of_care